Page last updated: 2024-08-23

triamcinolone and Amaurosis

triamcinolone has been researched along with Amaurosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Barnes, R; Barry, R; Barthelmes, D; Bhandari, S; Gillies, M; Nguyen, V; Squirrell, D; Tan, T; Wang, N; Wells, JM1
Fukushima, A; Goto, R; Hikichi, Y; Kitano, S; Sakamoto, T; Vataire, AL1
Gariano, RF; Paulus, YM1
POLANO, MK1
SNEDDON, IB1
BJOERNBERG, A; BJOERNBERG, K; GISSLEN, H1
Haritoglou, C; Kampik, A1
Freilich, DB; Grieco, MH; Louria, DB1

Reviews

1 review(s) available for triamcinolone and Amaurosis

ArticleYear
Diabetic retinopathy: a growing concern in an aging population.
    Geriatrics, 2009, Volume: 64, Issue:2

    Topics: Aged; Aged, 80 and over; Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Blindness; California; Diabetic Retinopathy; Drug Therapy, Combination; Geriatrics; Glucocorticoids; Humans; Incidence; Injections, Intralesional; Laser Coagulation; Mass Screening; Randomized Controlled Trials as Topic; Ranibizumab; Risk Factors; Treatment Outcome; Triamcinolone

2009

Other Studies

7 other study(ies) available for triamcinolone and Amaurosis

ArticleYear
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry.
    Eye (London, England), 2022, Volume: 36, Issue:3

    Topics: Angiogenesis Inhibitors; Bevacizumab; Blindness; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Registries; Retrospective Studies; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A

2022
The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in Japan.
    Journal of medical economics, 2019, Volume: 22, Issue:3

    Topics: Aged; Angiogenesis Inhibitors; Blindness; Caregivers; Cost of Illness; Cost-Benefit Analysis; Diabetes Complications; Efficiency; Female; Humans; Intravitreal Injections; Japan; Macular Edema; Male; Markov Chains; Middle Aged; Models, Econometric; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone; Visual Acuity

2019
Triamcinolone acetonide cream in a double-blind test.
    Archives of dermatology, 1961, Volume: 83

    Topics: Blindness; Double-Blind Method; Eczema; Humans; Triamcinolone; Triamcinolone Acetonide

1961
BLIND COMPARATIVE TRIAL OF FLUPEROLONE.
    The British journal of dermatology, 1963, Volume: 75

    Topics: Administration, Topical; Blindness; Eczema; Hydrocortisone; Methylprednisolone; Prednisolone; Triamcinolone

1963
TOXIC EPIDERMAL NECROLYSIS WITH OPTHALMIC COMPLICATIONS.
    Acta ophthalmologica, 1964, Volume: 42

    Topics: Blindness; Cathartics; Chlordiazepoxide; Corneal Ulcer; Cushing Syndrome; Demeclocycline; Drug Therapy; Eye Manifestations; Glycosuria; Humans; Keratoconjunctivitis; Osteoporosis; Phenacetin; Phenolphthaleins; Pyelonephritis; Stevens-Johnson Syndrome; Toxicology; Triamcinolone

1964
[Surgical therapy of diabetic retinopathy].
    Klinische Monatsblatter fur Augenheilkunde, 2005, Volume: 222, Issue:4

    Topics: Blindness; Blood Glucose; Diabetic Retinopathy; Fluorescein Angiography; Humans; Laser Coagulation; Macular Edema; Retina; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vitreoretinopathy, Proliferative

2005
Diagnosis of cryptococcal uveitis with hypertonic media.
    American journal of ophthalmology, 1971, Jul-30, Volume: 72, Issue:1

    Topics: Agglutination Tests; Amphotericin B; Antigens; Blindness; Cataract; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus; Culture Media; Humans; Hypertonic Solutions; Male; Methods; Middle Aged; Retinal Detachment; Rubber; Sucrose; Triamcinolone; Uveitis

1971